Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Therapeutic Cell Type

  2.3.2 Market Size By Therapeutic Application

  2.3.3 Market Size By In Vivo Cell Engineering Technology

  2.3.4 Market Size By Delivery Modality

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO's Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter's) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1. Gene & Vector Design, Engineering & Research Tool Providers

  3.4.2. In Vivo Cell Therapy Developers & Biopharmaceutical Sponsors

  3.4.3. Contract Development, Manufacturing & Regulatory Service Providers

  3.4.4. Treatment Centers, Payers & End Patients

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Clinical & Regulatory Milestone Tracking

  4.1.1 IND/CTA Clearance & Trial Initiation Timelines

  4.1.2 Orphan & Rare Pediatric Disease Designations

  4.1.3 Boxed Warning & Safety Labeling Developments

  4.1.4 Regional Regulatory Pathway Comparisons

 4.2 Deal & Investment Activity

  4.2.1 M&A and Licensing Deal Value Trends

  4.2.2 Venture & Strategic Financing Rounds

  4.2.3 Biobucks & Milestone Payment Structures

  4.2.4 Big Pharma Entry & Portfolio Positioning

 4.3 Platform & Technology Benchmarking

  4.3.1 Viral Vector vs Lipid Nanoparticle Delivery Comparisons

  4.3.2 Receptor Engineering vs Gene Editing Approaches

  4.3.3 Preclinical to Clinical Translation Rates

  4.3.4 Manufacturing Simplification Metrics

 4.4 Disease Area & Patient Access

  4.4.1 Hematological vs Solid Tumor Program Distribution

  4.4.2 Autoimmune Disease Pipeline Expansion

  4.4.3 Patient Access & Treatment Center Readiness

  4.4.4 Regional Cancer Burden & Unmet Need

 4.5 Competitive & Pipeline Intelligence

  4.5.1 Company Pipeline Depth & Lead Candidate Positioning

  4.5.2 Clinical Trial Enrollment & Site Expansion

  4.5.3 Partnership & Licensing Network Mapping

  4.5.4 Next-Generation Platform Differentiation

5. In Vivo Cell Therapy Market Segmental Analysis, By Therapeutic Cell Type

 5.1 Introduction

 5.2 T Cells

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Natural Killer Cells

 5.4 Myeloid Cells

 5.5 Hematopoietic Stem Cells

6. In Vivo Cell Therapy Market Segmental Analysis, By Therapeutic Application

 6.1 Introduction

 6.2 Hematological Malignancies

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Solid Tumors

 6.4 Autoimmune Diseases

 6.5 Genetic & Rare Disorders

7. In Vivo Cell Therapy Market Segmental Analysis, By In Vivo Cell Engineering Technology

 7.1 Introduction

 7.2 Receptor Engineering

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Gene Editing & Gene Modification

 7.4 Cell Reprogramming

 7.5 Epigenetic Modulation

8. In Vivo Cell Therapy Market Segmental Analysis, By Delivery Modality

 8.1 Introduction

 8.2 Viral Vector-Based

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Lipid Nanoparticle-Based

 8.4 Non-Viral Physical Delivery

 8.5 Others

9. In Vivo Cell Therapy Market Segmental Analysis, By Region

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Cell Type, 2022–2035

  9.2.3 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Application, 2022–2035

  9.2.4 In Vivo Cell Therapy Market Size & Forecast, By In Vivo Cell Engineering Technology, 2022–2035

  9.2.5 In Vivo Cell Therapy Market Size & Forecast, By Delivery Modality, 2022–2035

  9.2.6 In Vivo Cell Therapy Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 US

   9.2.6.2 Canada

 9.3 Europe

  9.3.1 Key Trends

  9.3.2 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Cell Type, 2022–2035

  9.3.3 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Application, 2022–2035

  9.3.4 In Vivo Cell Therapy Market Size & Forecast, By In Vivo Cell Engineering Technology, 2022–2035

  9.3.5 In Vivo Cell Therapy Market Size & Forecast, By Delivery Modality, 2022–2035

  9.3.6 In Vivo Cell Therapy Market Size & Forecast, By Country, 2022–2035

   9.3.6.1 Germany

   9.3.6.2 France

   9.3.6.3 UK

   9.3.6.4 Italy

   9.3.6.5 Spain

   9.3.6.6 Poland

   9.3.6.7 Russia

   9.3.6.8 Rest of Europe

 9.4 Asia Pacific

  9.4.1 Key Trends

  9.4.2 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Cell Type, 2022–2035

  9.4.3 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Application, 2022–2035

  9.4.4 In Vivo Cell Therapy Market Size & Forecast, By In Vivo Cell Engineering Technology, 2022–2035

  9.4.5 In Vivo Cell Therapy Market Size & Forecast, By Delivery Modality, 2022–2035

  9.4.6 In Vivo Cell Therapy Market Size & Forecast, By Country, 2022–2035

   9.4.6.1 China

   9.4.6.2 India

   9.4.6.3 Japan

   9.4.6.4 South Korea

   9.4.6.5 Australia

   9.4.6.6 ASEAN Countries

   9.4.6.7 Rest of Asia Pacific

 9.5 Latin America

  9.5.1 Key Trends

  9.5.2 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Cell Type, 2022–2035

  9.5.3 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Application, 2022–2035

  9.5.4 In Vivo Cell Therapy Market Size & Forecast, By In Vivo Cell Engineering Technology, 2022–2035

  9.5.5 In Vivo Cell Therapy Market Size & Forecast, By Delivery Modality, 2022–2035

  9.5.6 In Vivo Cell Therapy Market Size & Forecast, By Country, 2022–2035

   9.5.6.1 Brazil

   9.5.6.2 Argentina

   9.5.6.3 Mexico

   9.5.6.4 Colombia

   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa

  9.6.1 Key Trends

  9.6.2 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Cell Type, 2022–2035

  9.6.3 In Vivo Cell Therapy Market Size & Forecast, By Therapeutic Application, 2022–2035

  9.6.4 In Vivo Cell Therapy Market Size & Forecast, By In Vivo Cell Engineering Technology, 2022–2035

  9.6.5 In Vivo Cell Therapy Market Size & Forecast, By Delivery Modality, 2022–2035

  9.6.6 In Vivo Cell Therapy Market Size & Forecast, By Country, 2022–2035

   9.6.6.1 UAE

   9.6.6.2 Saudi Arabia

   9.6.6.3 Qatar

   9.6.6.4 South Africa

   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

  10.6.1 Gilead Sciences, Inc.

   10.6.1.1 Company Overview & Snapshot

   10.6.1.2 Product/Service Portfolio

   10.6.1.3 Key Company Financials

   10.6.1.4 Geographical Presence

   10.6.1.5 SWOT Analysis

  10.6.2 Legend Biotech Corporation

  10.6.3 Eli Lilly and Company

  10.6.4 AbbVie Inc.

  10.6.5 AstraZeneca plc

  10.6.6 Bristol Myers Squibb Company

  10.6.7 CRISPR Therapeutics AG

  10.6.8 Umoja Biopharma, Inc.

  10.6.9 Ensoma, Inc.

  10.6.10 Tessera Therapeutics, Inc.

  10.6.11 Sana Biotechnology, Inc.

  10.6.12 Pregene Biopharma Co., Ltd.

  10.6.13 CREATE Medicines, Inc.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures